PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23251633-0	2012	Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants.	Hexachlorophene	0-15	potassium voltage-gated channel subfamily Q member 1	Homo sapiens	28-33	
23251633-4	2012	In this study we report that hexachlorophene (HCP), the active component of the topical anti-infective prescription drug pHisoHex, is a KCNQ1/KCNE1 activator.	Hexachlorophene	29-44	potassium voltage-gated channel subfamily Q member 1	Homo sapiens	136-141	
23251633-4	2012	In this study we report that hexachlorophene (HCP), the active component of the topical anti-infective prescription drug pHisoHex, is a KCNQ1/KCNE1 activator.	Hexachlorophene	46-49	potassium voltage-gated channel subfamily Q member 1	Homo sapiens	136-141	
23251633-5	2012	HCP potently increases the current amplitude of KCNQ1/KCNE1 expressed by stabilizing the channel in an open state with an EC(50) of 4.61 +- 1.29 muM.	Hexachlorophene	0-3	potassium voltage-gated channel subfamily Q member 1	Homo sapiens	48-53	
23251633-8	2012	Our results indicate HCP is a novel KCNQ1/KCNE1 activator and may be a useful tool compound for the development of LQTs therapeutics.	Hexachlorophene	21-24	potassium voltage-gated channel subfamily Q member 1	Homo sapiens	36-41